NuCana plc (NCNA) stock
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.86−0.07 (-7.19%)
Close on Nov 16, 2026Market cap $3.59MP/E –Yield –
NuCana cash
Cash and short-term investments held at the end of each period.
NuCana's cash was £19.50M at Jun 30, 2026. For fiscal 2025 it was £24.25M, up 259.3% from the year before. Over ten years it grew 5.6% a year on average. The highest annual figure on record is £87.36M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | £24.25M | +259.3% |
| FY2024 | Dec 31, 2024 | £6.75M | -60.8% |
| FY2023 | Dec 31, 2023 | £17.23M | -58.9% |
| FY2022 | Dec 31, 2022 | £41.91M | -30.5% |
| FY2021 | Dec 31, 2021 | £60.26M | -31.0% |
| FY2020 | Dec 31, 2020 | £87.36M | +68.1% |
| FY2019 | Dec 31, 2019 | £51.96M | -32.5% |
| FY2018 | Dec 31, 2018 | £76.97M | -11.2% |
| FY2017 | Dec 31, 2017 | £86.70M | +333.7% |
| FY2016 | Dec 31, 2016 | £19.99M | +41.7% |
| FY2015 | Dec 31, 2015 | £14.11M | -24.8% |
| FY2014 | Dec 31, 2014 | £18.76M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | £19.50M | +67.6% |
| Q4 FY2025 | Dec 31, 2025 | £24.25M | +40.8% |
| Q2 FY2025 | Jun 30, 2025 | £8.44M | -65.7% |
| Q4 FY2024 | Dec 31, 2024 | £6.75M | -83.9% |
| Q2 FY2024 | Jun 30, 2024 | £11.64M | -75.0% |
| Q4 FY2023 | Dec 31, 2023 | £17.23M | -71.4% |
| Q2 FY2023 | Jun 30, 2023 | £24.64M | -65.3% |
| Q4 FY2022 | Dec 31, 2022 | £41.91M | -42.9% |
| Q2 FY2022 | Jun 30, 2022 | £46.53M | -40.8% |
| Q4 FY2021 | Dec 31, 2021 | £60.26M | -31.0% |
| Q3 FY2021 | Sep 30, 2021 | £71.03M | -29.5% |
| Q2 FY2021 | Jun 30, 2021 | £73.42M | +53.6% |
| Q1 FY2021 | Mar 31, 2021 | £78.63M | +65.2% |
| Q4 FY2020 | Dec 31, 2020 | £87.36M | +68.1% |
| Q3 FY2020 | Sep 30, 2020 | £100.68M | +73.3% |
| Q2 FY2020 | Jun 30, 2020 | £47.80M | -26.7% |
| Q1 FY2020 | Mar 31, 2020 | £47.60M | -31.9% |
| Q4 FY2019 | Dec 31, 2019 | £51.96M | -32.5% |
| Q3 FY2019 | Sep 30, 2019 | £58.09M | -25.9% |
| Q2 FY2019 | Jun 30, 2019 | £65.17M | -20.0% |
| Q1 FY2019 | Mar 31, 2019 | £69.91M | -14.1% |
| Q4 FY2018 | Dec 31, 2018 | £76.97M | -11.2% |
| Q3 FY2018 | Sep 30, 2018 | £78.35M | +517.8% |
| Q2 FY2018 | Jun 30, 2018 | £81.47M | +411.8% |
| Q1 FY2018 | Mar 31, 2018 | £81.34M | +306.9% |
| Q4 FY2017 | Dec 31, 2017 | £86.70M | +514.4% |
| Q3 FY2017 | Sep 30, 2017 | £12.68M | -32.4% |
| Q2 FY2017 | Jun 30, 2017 | £15.92M | – |
| Q4 FY2016 | Dec 31, 2016 | £19.99M | – |
| Q4 FY2015 | Dec 31, 2015 | £14.11M | – |
| Q4 FY2014 | Dec 31, 2014 | £18.76M | – |
See a number that looks wrong?